Mediators of Asthma: Nitric oxide

Author： Fischer A.   Folkerts G.   Geppetti P.   Groneberg D.A.  

Publisher： Academic Press

ISSN： 1094-5539

Source： Pulmonary Pharmacology & Therapeutics, Vol.15, Iss.2, 2002-05, pp. : 73-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitric Oxide in Asthma Therapy

By  

Current Pharmaceutical Design, Vol. 12, Iss. 25, 2006-09 ,pp. : 3221-3232

Bentham Science Publishers

Access to resources Recommend Favorite

Exhaled Nitric Oxide in Asthma in Adults: The End is the Beginning?

By  

Current Medicinal Chemistry, Vol. 18, Iss. 10, 2011-04 ,pp. : 1423-1431

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines and nitric oxide synthase inhibitor as mediators of adrenergic refractoriness in cardiac myocytes

By Oddis C.V.   Finkel M.S.  

European Journal of Pharmacology, Vol. 320, Iss. 2, 1997-02 ,pp. : 167-174

Elsevier

Access to resources Recommend Favorite

Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness

By Meurs H.   Maarsingh H.   Zaagsma J.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 9, 2003-09 ,pp. : 450-455

Elsevier

Access to resources Recommend Favorite

The Role of Exhaled Nitric Oxide in the Diagnosis, Management and Treatment of Asthma

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-01 ,pp. : 541-544

Bentham Science Publishers

Access to resources Recommend Favorite